Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Non Operating Income (2016 - 2025)

Utah Medical Products has reported Non Operating Income over the past 16 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$2.2 million for Q4 2025, up 19.83% from a year ago — trailing twelve months through Dec 2025 was -$120000.0 (up 31.03% YoY), and the annual figure for FY2025 was -$120000.0, down 11900.0%.
  • Non Operating Income for Q4 2025 was -$2.2 million at Utah Medical Products, down from $698000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for UTMD hit a ceiling of $915000.0 in Q1 2024 and a floor of -$2.7 million in Q4 2024.
  • Median Non Operating Income over the past 5 years was $419000.0 (2022), compared with a mean of $57950.0.
  • Peak annual rise in Non Operating Income hit 8400.0% in 2023, while the deepest fall reached 1139.38% in 2023.
  • Utah Medical Products' Non Operating Income stood at $880000.0 in 2021, then crashed by 118.18% to -$160000.0 in 2022, then crashed by 1139.38% to -$2.0 million in 2023, then plummeted by 36.06% to -$2.7 million in 2024, then rose by 19.83% to -$2.2 million in 2025.
  • The last three reported values for Non Operating Income were -$2.2 million (Q4 2025), $698000.0 (Q3 2025), and $640000.0 (Q2 2025) per Business Quant data.